Results 61 to 70 of about 33,599 (301)
Table_2_Physicians’ attitudes toward hypnotics for insomnia: A questionnaire-based study.DOCX
IntroductionBenzodiazepines and non-benzodiazepines are still widely prescribed despite safety concerns and the introduction of novel hypnotics (orexin receptor antagonists [ORA] and melatonin receptor agonists [MRA]), which may be influenced by ...
Ken Inada (12553528) +10 more
core +1 more source
Plasma and breast milk pharmacokinetics of suvorexant in healthy lactating women
Aim This paper aims to evaluate the plasma and breast milk pharmacokinetics of suvorexant, an orexin receptor antagonist used to treat insomnia at a maximum dose of 20 mg, in healthy lactating women. Methods The paper reports on an open‐label Phase 1 study in 12 healthy lactating women.
Jacqueline McCrea +10 more
wiley +1 more source
ANESTHETIC, ANALGETIC, HYPNOTIC – ARE THE TERMS IMPORTANT?
The review is devoted to pharmacology of the general anesthesia in the light of current understanding of this event and as a medical technique. The discussion covers the classification of medications used for general anesthesia basing on action mechanisms
A. E. Karelov +2 more
doaj +1 more source
Many patients with fragile X syndrome (FXS) have sleep disturbances, and Fmr1 knockout (KO) mice (a model of FXS) have reduced sleep duration compared to wild type (WT).
Rachel Michelle Saré +2 more
doaj +1 more source
Aims This study aimed to investigate the incidence of low‐dose quetiapine initiation and associated factors in adults newly diagnosed with depression in primary care. Methods We obtained medication dispensing records, primary and secondary care diagnoses and employment status for antipsychotic‐naïve individuals aged 16–65 newly diagnosed with ...
Laura Purra +5 more
wiley +1 more source
Sociodemographic and hypnotics use characteristics (N = 76).
Sociodemographic and hypnotics use characteristics (N = 76).
Daniela Fernández Curado (4971688) +6 more
core +1 more source
Abstract Cyclizine is a long‐established, short‐acting drug, registered for preventing motion sickness, post‐operative nausea and vomiting (PONV) and ‘vomiting of known cause’. The latter is not defined but may include pregnancy and patients receiving palliative care, historically accepted without large, controlled trials.
Gareth J. Sanger, Paul L. R. Andrews
wiley +1 more source
CERTAIN ASPECTS OF THE CHEMOTHERAPY OF SYNTHETIC HYPNOTICS.
CERTAIN ASPECTS OF THE CHEMOTHERAPY OF SYNTHETIC ...
S. R. UPENDRA NATH BRAHMACHARI
core +1 more source
Abstract Aim Critical care for COVID‐19 patients presents unique challenges, particularly in sedation management. Patients demonstrate notable dose‐related resistance to propofol, potentially due to complex pharmacokinetic alterations. Emerging evidence suggests that plasma extracellular vesicle‐associated miRNA represents valuable predictive ...
Debora Curci +10 more
wiley +1 more source

